References
- Al-Ali, H., Schurer, S.C., Lemmon, V.P., & Bixby, J.L. (2013). Chemical interrogation of the neuronal kinome using a primary cell-based screening assay. ACS Chemical Biology, 8, 1027–1036.doi: https://doi.org/10.1021/cb300584e.
- Anastassiadis, T., Deacon, S.W., Devarajan, K., Ma, H., & Peterson, J.R. (2011). Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nature Biotechnology, 29, 1039–1045.doi: https://doi.org/10.1038/nbt.2017.
- Autry, A.E., Adachi, M., Nosyreva, E., Na, E.S., Los, M.F., Cheng, P.F., … Monteggia, L.M. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature, 475, 91–95.doi: https://doi.org/10.1038/nature10130.
- Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., & Krystal, J.H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47, 351–354.doi: https://doi.org/10.1016/S0006-3223(99)00230-9.
- Beurel, E. (2014). Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders. Neuroimmunomodulation, 21, 140–144.doi: https://doi.org/10.1159/000356550.
- Beurel, E., Song, L., & Jope, R.S. (2011). Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Molecular Psychiatry, 16, 1068–1070.doi: https://doi.org/10.1038/mp.2011.47.
- Cooper, M.J., Cox, N.J., Zimmerman, E.I., Dewar, B.J., Duncan, J.S., Whittle, M.C., … Graves, L.M. (2013). Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia. PLoS One, 8, e66755. doi: 10.1371/journal.pone.0066755.
- Cotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry, 58, 545–553.doi: https://doi.org/10.1001/archpsyc.58.6.545.
- Daub, H., Olsen, J.V., Bairlein, M., Gnad, F., Oppermann, F.S., Korner, R., … Mann, M. (2008). Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Molecular Cell, 31, 438–448.doi: https://doi.org/10.1016/j.molcel.2008.07.007.
- Duman, C.H., Schlesinger, L., Kodama, M., Russell, D.S., & Duman, R.S. (2007). A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry, 61, 661–670.doi: https://doi.org/10.1016/j.biopsych.2006.05.047.
- Duncan, J.S., Whittle, M.C., Nakamura, K., Abell, A.N., Midland, A.A., Zawistowski, J.S., … Johnson, G.L. (2012). Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell, 149, 307–321.doi: 10.1016/j.cell.2012.02.053.
- Duric, V., Banasr, M., Licznerski, P., Schmidt, H.D., Stockmeier, C.A., Simen, A.A., … Duman, R.S. (2010). A negative regulator of MAP kinase causes depressive behavior. Nature Medicine, 16, 1328–1332.doi: https://doi.org/10.1038/nm.2219.
- Duric, V., Clayton, S., Leong, M.L., & Yuan, L.L. (2016). Comorbidity factors and brain mechanisms linking chronic stress and systemic illness. Neural Plasticity, 2016, 5460732. doi: https://doi.org/10.1155/2016/5460732.
- Duric, V., & Duman, R.S. (2013). Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cellular and Molecular Life Science, 70, 39–53.doi: https://doi.org/10.1007/s00018-012-1020-7.
- Dwivedi, Y., Rizavi, H.S., Conley, R.R., & Pandey, G.N. (2006). ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Molecular Psychiatry, 11, 86–98.doi: https://doi.org/10.1038/sj.mp.4001744.
- Dwivedi, Y., Rizavi, H.S., Roberts, R.C., Conley, R.C., Tamminga, C.A., & Pandey, G.N. (2001). Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. Journal of Neurochemistry, 77, 916–928.doi: https://doi.org/10.1046/j.1471-4159.2001.00300.x.
- Dwivedi, Y., Rizavi, H.S., Teppen, T., Sasaki, N., Chen, H., Zhang, H., … Pandey, G.N. (2007). Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology, 32, 2338–2350.doi: https://doi.org/10.1038/sj.npp.1301372.
- Fabian, M.A., Biggs, W.H., 3rd, Treiber, D.K., Atteridge, C.E., Azimioara, M.D., Benedetti, M.G., … Lockhart, D.J. (2005). A small molecule-kinase interaction map for clinical kinase inhibitors. Nature Biotechnology, 23, 329–336.doi: https://doi.org/10.1038/nbt1068.
- Feyissa, A.M., Chandran, A., Stockmeier, C.A., & Karolewicz, B. (2009). Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry, 33, 70–75.doi: https://doi.org/10.1016/j.pnpbp.2008.10.005.
- Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., … Daub, H. (2003). An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 100, 15434–15439.doi: https://doi.org/10.1073/pnas.2535024100.
- Graves, L.M., Duncan, J.S., Whittle, M.C., & Johnson, G.L. (2013). The dynamic nature of the kinome. The Biochemical Journal, 450, 1–8.doi: https://doi.org/10.1042/BJ20121456.
- Grewal, S.S., York, R.D., & Stork, P.J. (1999). Extracellular-signal-regulated kinase signalling in neurons. Current Opinion in Neurobiology, 9, 544–553.doi: https://doi.org/10.1016/S0959-4388(99)00010-0.
- Hercher, C., Turecki, G., & Mechawar, N. (2009). Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. Journal of Psychiatric Research, 43, 947–961.doi: https://doi.org/10.1016/j.jpsychires.2009.01.006.
- Hirschfeld, R.M. (2000). History and evolution of the monoamine hypothesis of depression. Journal of Clinical Psychiatry, 61, 4–6.doi: https://doi.org/10.4088/JCP.v61n0405.
- Hoozemans, J.J., Hilhorst, R., Ruijtenbeek, R., Rozemuller, A.J., & van der Vies, S.M. (2012). Protein kinase activity profiling of postmortem human brain tissue. Neurodegenerative Diseases, 10, 46–48.doi: https://doi.org/10.1159/000335914.
- Hyman, S.E., & Nestler, E.J. (1996). Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry, 153, 151–162.doi: https://doi.org/10.1176/ajp.153.2.151.
- Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., & Walters, E.E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.doi: https://doi.org/10.1001/archpsyc.62.6.617.
- Knockaert, M., Gray, N., Damiens, E., Chang, Y.T., Grellier, P., Grant, K., … Meijer, L. (2000). Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chemistry & Biology, 7, 411–422.doi: 10.1016/S1074-5521(00)00124-1.
- Kockeritz, L., Doble, B., Patel, S., & Woodgett, J.R. (2006). Glycogen synthase kinase-3-an overview of an over-achieving protein kinase. Current Drug Targets, 7, 1377–1388.doi: https://doi.org/10.2174/1389450110607011377.
- Kodama, M., Russell, D.S., & Duman, R.S. (2005). Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain. Neuropsychopharmacology, 30, 360–371.doi: https://doi.org/10.1038/sj.npp.1300588.
- Li, N., Lee, B., Liu, R.J., Banasr, M., Dwyer, J.M., Iwata, M., … Duman, R.S. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329, 959–964.doi: https://doi.org/10.1126/science.1190287.
- Li, N., Liu, R.J., Dwyer, J.M., Banasr, M., Lee, B., Son, H., … Duman, R.S. (2011). Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry, 69, 754–761.doi: https://doi.org/10.1016/j.biopsych.2010.12.015.
- MacBeath, G., & Schreiber, S.L. (2000). Printing proteins as microarrays for high-throughput function determination. Science, 289, 1760–1763.doi: https://doi.org/10.1126/science.289.5485.1760.
- Manning, G., Whyte, D.B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science, 298, 1912–1934.doi: https://doi.org/10.1126/science.1075762.
- Mathew, S.J., Shah, A., Lapidus, K., Clark, C., Jarun, N., Ostermeyer, B., & Murrough, J.W. (2012). Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs, 26, 189–204.doi: https://doi.org/10.2165/11599770-000000000-00000.
- Olsen, J.V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell, 127, 635–648.doi: https://doi.org/10.1016/j.cell.2006.09.026.
- Popoli, M., Brunello, N., Perez, J., & Racagni, G. (2000). Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. Journal of Neurochemistry, 74, 21–33.doi: https://doi.org/10.1046/j.1471-4159.2000.0740021.x.
- Seamans, J. (2008). Losing inhibition with ketamine. Nature Chemical Biology, 4, 91–93.doi: https://doi.org/10.1038/nchembio0208-91.
- Sheline, Y.I., Wang, P.W., Gado, M.H., Csernansky, J.G., & Vannier, M.W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America, 93, 3908–3913.doi: https://doi.org/10.1073/pnas.93.9.3908.
- Simon, G.E. (2003). Social and economic burden of mood disorders. Biological Psychiatry, 54, 208–215.doi: https://doi.org/10.1016/S0006-3223(03)00420-7.
- Stockmeier, C.A., Mahajan, G.J., Konick, L.C., Overholser, J.C., Jurjus, G.J., Meltzer, H.Y., … Rajkowska, G. (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry, 56, 640–650.doi: https://doi.org/10.1016/j.biopsych.2004.08.022.
- Videbech, P., & Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. The American Journal of Psychiatry, 161, 1957–1966.doi: https://doi.org/10.1176/appi.ajp.161.11.1957.
- Wissing, J., Jansch, L., Nimtz, M., Dieterich, G., Hornberger, R., Keri, G., … Daub, H. (2007). Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Molecular & Cellular Proteomics: MCP, 6, 537–547.
- Xiao, Y., & Wang, Y. (2016). Global discovery of protein kinases and other nucleotide-binding proteins by mass spectrometry. Mass Spectrometry Reviews, 35, 601–619.doi: https://doi.org/10.1002/mas.21447.
- Yamamoto, T., Mori, T., & Katayama, Y. (2014). Microarray technologies for intracellular kinome analysis. Current Medicinal Chemistry, 21, 2542–2552.doi: https://doi.org/10.2174/0929867321666131212154153.
- Yuen, E.Y., Liu, W., Karatsoreos, I.N., Feng, J., McEwen, B.S., & Yan, Z. (2009). Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proceedings of the National Academy of Sciences of the United States of America, 106, 14075–14079.doi: https://doi.org/10.1073/pnas.0906791106.
- Zanos, P., Moaddel, R., Morris, P.J., Georgiou, P., Fischell, J., Elmer, G.I., … Gould, T.D. (2016). NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature, 533, 481–486.doi: https://doi.org/10.1038/nature17998.
- Zunszain, P.A., Horowitz, M.A., Cattaneo, A., Lupi, M.M., & Pariante, C.M. (2013). Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Molecular Psychiatry, 18, 1236–1241.doi: https://doi.org/10.1038/mp.2013.87.